Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Explainer-Who in the US benefits from $35 insulin?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
$35 insulin: Who in the US benefits?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden administration, referring to a provision of ...
pharmaphorum8 天
Why the drug pricing debate is focused on insulin
Unfortunately, the current drug pricing bill fails to take a holistic ... and Eli Lilly’s Humalog (insulin lispro) by 2024. The organisation plans to offer the biosimilars at a ‘significant ...
Detroit Free Press7 天
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...